Latest news with #FCAP
Business Wire
3 days ago
- Health
- Business Wire
Immersive AI Platform for Pathologists Set to Launch at CAP25 in Orlando
NORTHFIELD, Ill.--(BUSINESS WIRE)--A new virtual artificial intelligence (AI) platform for pathologists will debut at CAP25, September 13-16 in Orlando, to give pathologists experience with the technology. 'It's no risk, no pressure. Just discovery,' said CAP President Donald Karcher, MD, FCAP. 'This initiative is about giving pathologists a trusted environment to evaluate new tools and stay in control of how technology fits into pathology practice.' The College of American Pathologists' (CAP) platform, powered by PathPresenter's technology, will provide CAP members a safe, simulated space to explore cutting-edge AI tools used in pathology. From image analysis to diagnostic support, pathologists can interact with models in realistic patient scenarios without impacting care. 'It's no risk, no pressure. Just discovery,' said CAP President Donald Karcher, MD, FCAP. 'This initiative is about giving pathologists a trusted environment to evaluate new tools and stay in control of how technology fits into pathology practice.' Designed as both an educational tool and a discovery hub, the platform is set to become a go-to destination for pathologists exploring AI in real-world contexts when launched at CAP25. 'We wanted to give pathologists a space to explore how AI models can be used in real-world practice,' said M. E. (Doc) de Baca, MD, FCAP, CAP Council on Informatics and Pathology Innovation Chair. 'This platform not only highlights the AI tools currently available and also offers a glimpse of what's possible as we continue to investigate how AI can support and enhance the practice of pathology.' The platform will feature a slate of AI tools for the pathology community to test drive, with participation from vendors across the industry. Pathologists will be able to engage with real models, not just screenshots or quick demos. It's designed to meet the growing demand for meaningful, hands-on exploration of AI tools in a setting that supports learning and confidence. 'Pathologists are looking for more than marketing jargon,' said Rajendra Singh, MD, FCAP, co-founder of PathPresenter. 'They want evidence. They want to see first-hand how these tools perform, what problems they solve, and how they fit into real pathology workflows. This platform brings together the best of both worlds: innovative AI models and expert users who know how to critically evaluate them.' The initiative is guided by CAP leaders at the forefront of informatics, AI, and digital innovation, bringing deep expertise and a clear focus on what pathologists need most from emerging technologies. About the College of American Pathologists As the world's largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, visit the CAP Newsroom, and to watch pathologists at work and see the stories of the patients who trust them with their care. About PathPresenter PathPresenter is an enterprise image management and workflow platform for digital pathology. We are on a mission to democratize access to the world's pathology knowledge by connecting pathologists to the vast expertise of their colleagues globally and providing a practical platform to access and use best-in-class AI models. Founded by dermatopathologist and digital pathology pioneer Dr. Rajendra Singh, PathPresenter's secure, scalable, vendor-agnostic enterprise pathology workflow software has been adopted by tier one medical institutions for clinical care, education, and research, and the company has built a thriving community of tens of thousands of users around the world to easily view and share digital pathology images and knowledge. Learn more at
Yahoo
25-04-2025
- Business
- Yahoo
First Capital: Q1 Earnings Snapshot
CORYDON, Ind. (AP) — CORYDON, Ind. (AP) — First Capital Inc. (FCAP) on Friday reported profit of $3.2 million in its first quarter. The Corydon, Indiana-based company said it had profit of 97 cents per share. The bank holding company posted revenue of $15.2 million in the period. Its adjusted revenue was $11.4 million. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on FCAP at Sign in to access your portfolio
Associated Press
27-03-2025
- Health
- Associated Press
Imagene Laboratory Receives Accreditation From College of American Pathologists
Affirming the Growing Importance of AI-Driven Testing in Cancer Diagnostics PHOENIX, ARIZONA / ACCESS Newswire / March 27, 2025 / The Accreditation Committee of the College of American Pathologists (CAP) has recently awarded accreditation to Imagene Laboratory, Phoenix, Arizona, based on the results of a recent on‐site inspection as part of CAP's Accreditation Programs. Recognized for rigorous and robust standards, CAP accreditation elevates quality and mitigates risk, an important way that laboratories can contribute to improved patient Accreditation - Imagene 'We are proud that the College of American Pathologists has recognized our quality through this accreditation, reflecting our commitment to maintaining the highest standards of excellence in laboratory testing,' said Dan Milner, MD, Imagene's Laboratory Medical Director. 'As a laboratory that provides AI-driven tests, this accreditation not only validates our innovative approach but also assures its reliability and accuracy. Our laboratory, already CLIA-certified, has voluntarily pursued this accreditation to ensure that our quality systems remain best in class.' 'Imagene demonstrates leadership, innovation, and a passionate commitment to standards of excellence while providing the highest quality services, ultimately for patients,' said Richard M. Scanlan, MD, FCAP, chair of the CAP's Council on Accreditation. 'The CAP congratulates Imagene Laboratory on its recent CAP Accreditation.' During the CAP accreditation process, designed to ensure the highest standard of care for all laboratory patients, inspectors examine the laboratory's records and quality control of procedures. CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety program and record, and overall management. These reviews help verify that the Imagene laboratory meets the most recent best practice standards. With over 23,000 laboratory participants, in addition to accreditation, the CAP offers proficiency testing/external quality assessment (PT/EQA) programs, quality improvement tools, and protocols and guidelines to ensure excellence in all areas across the laboratory. Built on a foundation of pathologist expertise, the College of American Pathologists (CAP) partners with laboratories worldwide to elevate the quality of laboratory medicine with best-in-class solutions designed to drive operational, achieve diagnostic, and ensure the best patient care. About the College of American Pathologists As the world's largest organization of board-certified pathologists and a leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, visit the CAP Newsroom, and
Yahoo
10-02-2025
- Health
- Yahoo
Tuberculosis Is on the Rise—Should You Get the Vaccine?
Tuberculosis is making headlines as the contagious respiratory disease spreads in the Midwest. Kansas is currently facing one of the largest recorded outbreaks in United States history, according to local health officials and the Centers for Disease Control and Prevention (CDC). The good news: tuberculosis is both preventable and treatable. Here, doctors share everything to know about who should get the vaccine for tuberculosis (TB) and how it can protect your health, plus what symptoms look like. Tuberculosis is an infectious respiratory disease caused by bacteria that typically affects the lungs, but can also impact other organs. It's transmitted through the air when people with TB cough, sneeze or sing—though not from sharing food, shaking hands or kissing, the CDC reports. Also, babies and children are at a higher risk of developing TB. In some cases, tuberculosis germs can live in the body for years without ever making someone sick or being contagious. This is called a latent or dormant TB infection. Without treatment, a latent TB infection can develop into an active TB infection that is contagious, causes symptoms and requires medical treatment. Someone with an active TB infection who is contagious may display symptoms such as: Prolonged cough (sometimes with blood—often the telltale sign) Chest pain Weakness Fatigue Weight loss Fever Night sweats With cases of TB on the rise, you're likely wondering how to protect yourself. The problem? The Bacille Calmette-Guérin (BCG) vaccine for tuberculosis is usually not recommended in the U.S. for adults. 'The TB vaccine is mainly given to babies and small children in countries where TB is common,' says Tess Karre, MD, FCAP, a member of the College of American Pathologists' Microbiology Committee. 'It helps protect against severe forms of the disease such as when it involves the brain or spreads throughout the entire body.' In the U.S., the vaccine isn't used often because TB is rare, and other methods, like testing and antibiotics, are used to control it, Dr. Karre explains. However, some people might still benefit from getting the tuberculosis vaccine, such as: Children who are continually exposed through a family or household member with active TB and who cannot receive preventive treatment for TB infection. Healthcare workers who work in settings with a high risk of exposure to bacteria strains that are resistant to TB antibiotics. Dr. Karre believes it is unlikely that the U.S. will adjust its BCG vaccination guidelines in the near future. Despite the current tuberculosis outbreak, the disease has not reached the level of endemicity in this country necessary to make the benefits of the vaccine outweigh the costs and risks, she explains. As Dr. Karre stated, the best way to manage TB and prevent a latent infection from developing into an active infection is through early diagnosis and treatment. You should seek medical care if you have any of the symptoms listed above—specifically night sweats or coughing up blood, says Lily Grobman, PA, a MinuteMed Contributor. Screening for tuberculosis annually is very important for people who work in high-risk populations, she adds. 'Currently, due to the outbreak of tuberculosis in Kansas, we strongly recommend anyone living there who is at high risk or experiencing symptoms be tested,' Grobman says. 'Consider online services such as for searching for various test sites. Early intervention is key in preventing further spreading of the highly contagious bacteria.' There are two common TB tests to help diagnose the condition:During a tuberculin skin test (TST), a small amount of the TB protein is injected under the skin and evaluated 48 hours later to see if the area becomes raised. A QuantiFERON-TB Gold Test (QFT), or IGRA test, is a blood test that examines how your immune system reacts when a sample of your blood is mixed with TB proteins. 'Once there is a positive TB result, a chest x-ray will be done to detect any active disease,'Grobman says. 'Both active and latent tuberculosis will need to be treated, but with different medication regimens.' Your doctor will prescribe one or more medications to treat a tuberculosis infection. Active infections are typically treated for four, six or nine months, while latent infections may be treated for three to four months, the Mayo Clinic reports. More info on respiratory illnesses: How to Test Yourself for COPD at Home, Plus Early Warning Signs It's Time to See a Doctor What Is White Lung Pneumonia, and Should You Be Worried This Sick Season? A Lung Doctor Weighs In RSV Symptoms in Adults: How To Tell if Your Cough Is More Than Just a Cold This content is not a substitute for professional medical advice or diagnosis. Always consult your physician before pursuing any treatment plan.
